ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAB1. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,117,000 | +73.1% | 3,000,000 | 0.0% | 0.01% | +66.7% |
| Q1 2019 | $5,267,000 | -72.2% | 3,000,000 | -80.9% | 0.00% | -76.9% |
| Q4 2018 | $18,948,000 | -52.1% | 15,685,000 | -50.0% | 0.01% | +8.3% |
| Q3 2018 | $39,590,000 | -5.9% | 31,370,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $42,065,000 | – | 31,370,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bluefin Trading, LLC | 426,050 | $129,484,000 | 18.33% |
| CSS LLC/IL | 20,740,000 | $63,098,000 | 3.63% |
| Weiss Asset Management LP | 10,225,000 | $31,105,000 | 1.89% |
| Redmile Group, LLC | 16,500,000 | $50,155,000 | 1.42% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,600,000 | $23,136,000 | 0.17% |
| LAZARD ASSET MANAGEMENT LLC | 10,690,000 | $32,542,000 | 0.05% |
| SG Americas Securities, LLC | 9,000 | $2,740,000 | 0.02% |
| DEUTSCHE BANK AG\ | 3,000,000 | $9,117,000 | 0.01% |
| Jefferies Group LLC | 230,000 | $699,000 | 0.01% |
| Citadel Advisors | 3,000,000 | $9,129,000 | 0.00% |